News

KREAXI TV

Press Release

Amolyt Pharma selected for the French Tech 120 Program

Amolyt Pharma, a global company specialized in developing therapeutic peptides for rare endocrine and related diseases, today announced that the company has been selected for the French Tech FT120, a support program for French late-stage startups by the French State....